cbdMD Inc (YCBD)
0.432
-0.03
(-6.09%)
USD |
NYAM |
Nov 05, 16:00
0.432
0.00 (0.00%)
After-Hours: 18:20
cbdMD Enterprise Value: 0.719M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 0.719M |
| November 01, 2024 | 0.7152M |
| October 31, 2024 | 0.9072M |
| October 30, 2024 | 0.8695M |
| October 29, 2024 | 1.020M |
| October 28, 2024 | 1.020M |
| October 25, 2024 | 1.095M |
| October 24, 2024 | 1.019M |
| October 23, 2024 | 0.9726M |
| October 22, 2024 | 0.8959M |
| October 21, 2024 | 0.9444M |
| October 18, 2024 | 0.9072M |
| October 17, 2024 | 0.6061M |
| October 16, 2024 | 0.6475M |
| October 15, 2024 | 0.6938M |
| October 14, 2024 | 0.6437M |
| October 11, 2024 | 0.6287M |
| October 10, 2024 | 0.6644M |
| October 09, 2024 | 0.719M |
| October 08, 2024 | 0.7182M |
| October 07, 2024 | 0.7039M |
| October 04, 2024 | 0.7623M |
| October 03, 2024 | 0.719M |
| October 02, 2024 | 0.6855M |
| October 01, 2024 | 0.681M |
| Date | Value |
|---|---|
| September 30, 2024 | 0.7566M |
| September 27, 2024 | 0.7566M |
| September 26, 2024 | 0.7566M |
| September 25, 2024 | 0.7566M |
| September 24, 2024 | 0.8123M |
| September 23, 2024 | 0.7201M |
| September 20, 2024 | 0.7378M |
| September 19, 2024 | 0.798M |
| September 18, 2024 | 0.8394M |
| September 17, 2024 | 1.028M |
| September 16, 2024 | 0.9252M |
| September 13, 2024 | 0.9109M |
| September 12, 2024 | 0.9824M |
| September 11, 2024 | 0.9926M |
| September 10, 2024 | 1.058M |
| September 09, 2024 | 1.103M |
| September 06, 2024 | 1.133M |
| September 05, 2024 | 1.059M |
| September 04, 2024 | 1.014M |
| September 03, 2024 | 1.144M |
| August 30, 2024 | 1.035M |
| August 29, 2024 | 1.035M |
| August 28, 2024 | 0.9467M |
| August 27, 2024 | 1.061M |
| August 26, 2024 | 1.058M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-0.0433M
Minimum
Oct 31 2023
301.50M
Maximum
Feb 10 2021
51.03M
Average
25.05M
Median
Apr 19 2022
Enterprise Value Benchmarks
| MariMed Inc | 123.47M |
| Flora Growth Corp | 17.30M |
| NovaBay Pharmaceuticals Inc | 3.645M |
| Palatin Technologies Inc | 13.74M |
| iBio Inc | 9.837M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.4597M |
| Revenue (Quarterly) | 5.174M |
| Total Expenses (Quarterly) | 5.556M |
| EPS Diluted (Quarterly) | -0.15 |
| Gross Profit Margin (Quarterly) | 65.78% |
| Profit Margin (Quarterly) | 8.89% |
| Earnings Yield | -2.60K% |
| Normalized Earnings Yield | -1450.01 |